• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

Neurofilament article in JAMA Neurology

30 October 2018

A report from the TTM1 biobank on the use of neurofilament light chain (NFL) was published online today. The findings from this study suggest that the serum NFL level is a highly predictive marker of long-term poor neurologic outcome at 24 hours after cardiac arrest and may be a useful complement to currently available neurologic prognostication methods.

In the paper, written by Marion Moseby Knappe and co-workers from the TTM collaboration, NFL was compared to NSE (which is currently the only biomarker recommended by guidelines). NFL showed higher accuracy than NSE, and did so already at 24h after arrest. The paper is available here: https://jamanetwork.com/journals/jamaneurology/fullarticle/2709115

News

TTM2 Trial Results Meeting

08 June 2021

Protocol for the TTM2 follow-up published in Resuscitaiton

15 April 2020

Covid-19 update

20 March 2020

Randomisation Complete!

20 January 2020

TTM2 - Trial design article (open access).

16 November 2019

Formal Interim analysis

04 October 2019

1000!

29 May 2019

Investigator meeting in Lund 22 May

22 May 2019

Largest cardiac arrest trial in an ICU setting

22 May 2019

New FAQs

04 February 2019

Pages

  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org